Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport TAR-200 (Inlexzo) is Janssen's osmotic intravesical gemcitabine device targeting MIBC and high-risk NMIBC. Explore the patent landscape and Phase III pivotal data.
Article | Rapport Inclisiran's ORION-4 Phase III outcomes trial, siRNA vs PCSK9 antibody LDL-C reductions, MACE data, and the evolving cardiovascular IP landscape.
Article | Rapport Map the 2026 long read epigenome sequencing landscape: SMRT, nanopore, multimodal assays, and emerging IP signals across oncology, diagnostics, and agriculture.
Article | Rapport How iptacopan (Fabhalta) is reshaping PNH treatment by targeting Factor B orally — and what it means for ravulizumab and pegcetacoplan. Data-driven analysis.
Article | Rapport Explore the 2026 landscape of high-temperature PEM fuel cell membrane materials: PBI systems, phosphoric acid doping, MEA design, and key innovation trends.
Article | Rapport Explore how concurrent and sequential engineering development models differ for complex mechatronic product programs — and which approach accelerates R&D outcomes.
Article | Rapport Explore the key engineering tradeoffs between active and passive thermal control strategies for small satellite and CubeSat thermal management design.
Article | Rapport Explore the key differences between qualitative and quantitative accelerated aging protocols for polymer-based medical device materials, from Arrhenius models to shelf-life validation.
Article | Rapport Avidity Biosciences' AOC platform targets DM1 and DMD with antibody-oligonucleotide conjugates. Explore AOC 1001, AOC 1044, and Phase III readiness signals.
Article | Rapport Explore the supercapacitor electrode materials landscape in 2026: patent trends, key materials, and innovation intelligence for R&D and IP teams.
Article | Rapport A 2026 patent and literature landscape of grid-scale gravity energy storage: key mechanisms, assignees, emerging directions, and strategic IP implications.
Article | Rapport Wave-powered autonomous vessel patents 2012–2024: gyroscopic converters, hybrid energy systems, and AI navigation reshape zero-emission ocean operations.
Article | Rapport Gedatolisib (PKI-587) NDA filing in PIK3CA wild-type HR+/HER2− breast cancer: VIKTORIA-1 trial results, PI3K/mTOR pathway biology, and Celcuity/Pfizer strategy.
Article | Rapport Explore the 2026 all-solid-state battery stack materials landscape: solid electrolytes, electrode interfaces, stack architecture, and key patent filing trends.
Article | Rapport How engineers approach design for disassembly and material recovery in next-generation consumer electronics — key strategies, patent classes, and circular economy frameworks.